ImetelChat

Another excellent blog out today on SA: Elucidating The Substantial Prospects Of Imetelstat https://seekingalpha.com/instablog/17806842-biosci-capital-partners/5138970-elucidating-substantial-prospects-imetelstat Also was one last week by MedTechBio as well: Geron's Imetelstat Survival Data Is Much ...

Again I hope you are right or even close to right on this biopearl. I know there is great excitement building from an investors perspective, of which I am also, as well as the patients in need, so maybe I being a little cynical and jaded on the few experiences I’ve had, but the real world does have ...

Thanks for the encouragement Biopear, I hope you are totally right about it! From what I’ve read, the practice, called "off-label" prescribing, is entirely legal and very common. The FDA regulates drug approval, not drug prescribing. However, it probably isn’t as easy as one might think, and I hope ...

Given the new information associated with the earnings announcement, the CT processes are moving along. So hopefully we can soon see Imetelstat available to R/R MF patients and covered by insurance plans. But, given all the information available to the FDA, including information based on various mut...

Again, no claim to any expertise here but since most questions are okay on ImetelChat, I have significant concerns about statements by some that only patients with MF that are R/R to Ruxolitinib (Jakafi/Jakavi) will likely be considered by health insurance companies for coverage of Imetelstat once i...

Thanks Fishermanagents for your balanced thoughts on moving Imetelstat through the processes to those in need. Also, I am sorry for your loss and first hand experiences with these diseases. Your passion regarding Imetelstat has always reflected personal experience with these diseases, thanks again f...

Thanks, Fishermanagents for your detailed thoughts and personal experiences adding balance, intelligence and sanity to my limited views and thoughts as usual. I always learn from your posts and responses. I’m not trying to be negative here as I am mostly frustrated. I believe most people are doing t...

I have never understood the rationale of a 35% reduction in spleen size in the Geron MF R/R CT as one of the two primary outcome measures (POM). For completeness on this post I’m adding background regarding association with a relative with MF. I apologize for the length of this. He became R/R to ava...

Thanks Fishermanagents, I concur with all your thoughts, except that you are a simple private investor, as you have provided great insight and a very decent and useful forum for discussion and background. Otherwise we are all lost in this endeavor. Anyway, thanks for your feedback, as all the noise ...

Given Geron’s fiduciary responsibility to all shareholders and the company / employees themselves, are they doing everything they can to make sure the value of this company and their assets are properly presented, protected? And to not forget the ethical considerations around speeding the availabili...

I read this as no conference call after the earnings announcement on Friday and the conference call on Monday will cover both the earning and developments, correct?

This is an email question to Anna Krassowska, Geron IR and her explanation responses. While I think most are hoping for some specific details in near term communications, knowing the data has still not matured continues to be helpful. As basically all of us are hopeful for our friends and family and...

sdrawkcabeman post yesterday on the YMB: "I was just browsing the Geron homepage and noticed under the "For Patients" tab, there's a page for "Hematologic Malignancies." In the past, when they described hematologic malignancies, it was strictly in context of myeloid, they did't mention anything else...

Institutional ownership influence regarding shareholder acceptance of a Geron buyout offer Some SA comments seem to indicate the institutional ownership will control the BO deemed acceptable and it could be a low BO. Institutional ownership is less than 40% of Geron shares (159MM) at approximately 6...

Irishtrader52, yes best wishes and continued good health. I can’t remember any posts that are more poignant, hopeful, germane and of interest to all who follow what this is all about, than when you provide your updates and thoughts. While on one hand, I am still sad knowing what might have been for ...

Biopearl, your use of “spectacular” was not an overstatement imho. The cc was about as good as it could be without including such things like the detail readouts, continuation, NDA, AML CT announcements, etc. I’m not sure why or the considerations of intermediate MDS being left off the MDS trial nex...

Okay, thanks Biopearl, looks like I have missed something in all the tea leaves. Certainly given the various meetings and conferences coming, the earlier timing makes a lot of sense and not just a means of giving the bad news time to blow over before. Hopefully this will be handled with astute PR as...

Sorry for the double post, can the first one be deleted?

Geron has added a news release to its Investor Relations website. Title: Geron Announces Conference Call on April 10 at 8:00 A.M. Eastern Time Date(s): 9-Apr-2017 8:00 AM For a complete listing of our news releases, please click here http://ir.geron.com/phoenix.zhtml?c=67323&p=irol-newsArticle&ID=22...

Given the nature of the beast, it doesn’t go away if it is ignored, only the intelligent, constructive contributors go away or seldom comment as per the YMB. Isn’t that a success for the chimps? Seems to me either SA and YMB addresses it or it continues. It appears to me that they are not set up to ...